STOCK TITAN

Check-Cap Ltd. - $CHEK STOCK NEWS

Welcome to our dedicated page for Check-Cap Ltd. news (Ticker: $CHEK), a resource for investors and traders seeking the latest updates and insights on Check-Cap Ltd. stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Check-Cap Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Check-Cap Ltd.'s position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
none
-
Rhea-AI Summary
Check-Cap announces financial results for Q1 2023, including a temporary postponement of the powered portion of the U.S. pivotal study. The company is working with the FDA to amend the study protocol. Cost reductions are being implemented to extend cash runway.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.28%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-42.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.69%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.45%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.13%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
none
Check-Cap Ltd.

Nasdaq:CHEK

CHEK Rankings

CHEK Stock Data

12.87M
4.42M
25.16%
1.08%
10.26%
Irradiation Apparatus Manufacturing
Manufacturing
Link
United States of America
P O Box 1271

About CHEK

check-cap is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose x-rays for crc screening. the check-cap device requires no bowel preparation or invasive procedures, and is designed to detect clinically significant polyps with a high degree of sensitivity. check-cap's advanced technology has been proven in animals, and is designed to offer several advantages compared to current screening procedures. founded in early 2005, check-cap recruited a team of world-class experts in physics, software engineering, electronics, mechanics and physiology, who have been developing a multi-disciplinary imaging solution for imaging and screening of the colon. the system includes a capsule, a receiver, proprietary imaging software and an associated database for web based access and analysis. check-cap's advanced technology has been proven in animals and promises to offer several significant advantages compared to other colo